NBC SECURITIES, INC.

Broker-Dealer

Position in HALO — Halozyme Therapeutics, Inc.

CIK 791540 BIRMINGHAM, AL

Position in HALO

as of Jun 30, 2026 · filed Jul 21, 2026 Compact

Position Value

$815,103

+$86,077 QoQ

Shares Held

10,414

-7.7% QoQ

Ownership

0.009%

of shares outstanding

% of Portfolio

0.09%

of 13F equity value

Holder Rank

#331

of 664 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

NBC SECURITIES, INC. holds $5,111,855 across 54 Biotechnology names. HALO ranks #1 (15.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	HALO	Halozyme Therapeutics, Inc. This page	10,414	$815,103
2	AXSM	Axsome Therapeutics, Inc.	1,623	$397,261
3	TSHA	Taysha Gene Therapies, Inc.	55,022	$374,699
4	INBX	Inhibrx Biosciences, Inc.	3,900	$369,525
5	PTGX	Protagonist Therapeutics, Inc	2,545	$311,966
6	MIRM	Mirum Pharmaceuticals, Inc.	2,591	$303,328
7	REGN	Regeneron Pharmaceuticals, Inc.	435	$271,239
8	SRRK	Scholar Rock Holding Corp	4,479	$246,345

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$815,103	10,414	-7.7%	Shares	Sole	2026-07-21
2026-03-31	$729,026	11,280	0.0%	Shares	Sole	2026-04-14
2025-12-31	$759,144	11,280	-3.1%	Shares	Sole	2026-01-29
2025-09-30	$853,970	11,644	+0.1%	Shares	Sole	2025-11-14
2025-06-30	$604,836	11,627	-6.3%	Shares	Sole	2025-07-08
2025-03-31	$791,435	12,403	+620050.0%	Shares	Sole	2025-04-09
2024-12-31	$95	2	-99.9%	Shares	Sole	2025-01-22
2024-09-30	$131,823	2,303	-26.3%	Shares	Sole	2024-10-15
2024-06-30	$163,572	3,124	+155.6%	Shares	Sole	2024-07-10
2024-03-31	$49,710	1,222	0.0%	Shares	Sole	2024-04-05
2023-12-31	$45,165	1,222	-11.3%	Shares	Sole	2024-02-07
2023-09-30	$52,639	1,378	—	Shares	Sole	2023-11-03
No filing history on record for this holder in this stock.